About
Technology
Issues
FAQ
Links
Official Page
Assessing the Safety and Efficacy of Ruxolitinib in a Multicenter, Open-Label, Expanded-Access Study in Japanese Patients with Myelofibrosis (MF)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.